Scalp nerve block with liposomal versus standard bupivacaine for post-craniotomy pain relief
Official title: A Multicenter, Single-blind, Randomized Controlled Study on the Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy
Run by Zhejiang University · NCT07049094 · Data updated 2026-11-12
This trial will test whether adding liposomal bupivacaine to scalp nerve blocks gives longer, better pain relief than standard bupivacaine for adults after elective craniotomy.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 218 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | June 25, 2025 |
| Main results expected | June 25, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | July 3, 2025 |
| Trial ID | NCT07049094 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) scheduled for elective supratentorial craniotomy with ASA I–III, able to give informed consent, with preoperative GCS 15 and without significant preoperative headache or contraindications to nerve block are ideal candidates.
✕Probably not a fit
Patients with severe liver, renal, or heart failure, long-term opioid or steroid use, active infection or tumor at the puncture site, cognitive impairment, recent substance abuse, or preoperative headache NRS ≥4 are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, single-blind, controlled Phase 4 trial at Zhejiang University compares standard hydrochloride bupivacaine scalp nerve blocks with a combination that includes liposomal bupivacaine in adults undergoing elective cranial surgery. Eligible patients are randomized to receive either standard bupivacaine or bupivacaine plus liposomal formulation, with clinicians aware of allocation and patients blinded. Outcomes include postoperative pain scores, opioid consumption, recovery quality, and complications, with thorough preoperative neurological and laboratory assessments. The protocol uses validated pain scales and standardized scalp nerve block techniques to measure analgesic duration and safety.
Why it matters
Potential benefit: If successful, this approach could provide longer-lasting post-craniotomy pain relief, reduce opioid use and opioid-related side effects, and help speed recovery.
How similar studies have gone: Scalp nerve blocks are an established part of multimodal analgesia after craniotomy, but use of liposomal bupivacaine for extended scalp analgesia has limited and mixed evidence in this specific setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * ASA I-III * Scheduled for elective cranial surgery * Informed consent from the patient or legal representative Exclusion Criteria: * Preoperative Glasgow score \< 15 * Preoperative headache with NRS ≥ 4 * Anticipated postoperative sedation or extubation difficulties requiring mechanical ventilation * Inability to understand the numerical rating scale (NRS) * Allergies or contraindications to amide local anesthetics, opioids, or NSAIDs * Long-term opioid or corticosteroid treatment (\> 2 weeks) * History of drug abuse in the past 2 years * Daily alcohol consumption exceeding 3 standard doses * Mental or cognitive disorders affecting perioperative assessment * Contraindications for nerve blocks, including infection or tumors at the puncture site, diagnosed diabetic peripheral neuropathy, or inability to cooperate * Severe liver dysfunction (Child-Pugh class C), severe renal dysfunction (requiring dialysis preoperatively), or severe heart failure (METS \< 4) * Pregnant or breastfeeding women * History of craniotomy or pre-existing pathological pain conditions (e.g., migraines, trigeminal neuralgia) * Incisions for craniotomy extending beyond the area covered by the scalp nerve blocks * Participation in other clinical trials
Where it's running
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Diansan Su, PhD
- Email: diansansu@yahoo.com
- Phone: +8618616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain recovery after MCA reopening is studied with PET/MR
This study tests how brain blood flow, metabolism, and networks change after reopening a non-acute atherosclerotic middle cerebral artery occlusion in adults receiving recanalization treatment.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy
This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.
-
Adapted Physical Activity for adults with brain tumors
We’re testing whether a supervised adapted physical activity program is feasible for adults with primary brain tumors and what adherence looks like.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Skin closure after brain tumor surgery: running absorbable versus interrupted non-absorbable sutures
This will test whether absorbable running intradermal sutures or non-absorbable interrupted transdermal sutures produce better wound healing after craniotomy in adults with supratentorial brain tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.